98-31412. Center for Biologics Evaluation and Research Medical Device Action Plan; Public Meeting; Correction  

  • [Federal Register Volume 63, Number 227 (Wednesday, November 25, 1998)]
    [Notices]
    [Pages 65212-65213]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-31412]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98N-1002]
    
    
    Center for Biologics Evaluation and Research Medical Device 
    Action Plan; Public Meeting; Correction
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice of meeting; correction.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
    that appeared in the Federal Register of November 2, 1998 (63 FR 
    58743). The document announced an upcoming public meeting requesting 
    suggestions for improvements to the Center for Biologics Evaluation and 
    Research's regulation of medical devices or reasons to maintain the 
    current systems to protect public health. The notice inadvertently 
    omitted the date and addresses for the submissions of comments after 
    the meeting. This document corrects those omissions.
    
    FOR FURTHER INFORMATION CONTACT: Kathy A. Eberhart, Center for 
    Biologics Evaluation and Research (HFM-43), Food and Drug 
    Administration, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-827-
    1317.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of November 2, 1998 
    (63 FR 58743), in FR Doc. 98-29185, FDA announced an upcoming public 
    meeting requesting suggestions for improvements to the the Center for 
    Biologics Evaluation and Research's regulations of medical devices or 
    reasons to maintain the current systems to protect public health. The 
    notice inadvertently omitted the date and address for the submissions 
    of comments after the meeting.
        1. On page 58743, in the third column, under the Date and Time 
    caption, a second sentence is added to read ``Submit written comments 
    by December 22, 1998.''
        2. On the same page, after the ``Location'' portion, another 
    paragraph is added to read ``Addresses: Submit by December 22, 1998, 
    written comments to the Dockets Management Branch (HFA-305), Food and 
    Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. 
    Two copies of any comments are to be submitted, except that individuals 
    may submit one copy. Comments are to be identified with the docket 
    number found in brackets in the heading of this document. A copy and 
    received comments are available for public
    
    [[Page 65213]]
    
    examination in the Dockets Management Branch between 9 a.m. and 4 p.m., 
    Monday through Friday.''
    
        Dated: November 18, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-31412 Filed 11-24-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
11/25/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of meeting; correction.
Document Number:
98-31412
Pages:
65212-65213 (2 pages)
Docket Numbers:
Docket No. 98N-1002
PDF File:
98-31412.pdf